These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18537625)

  • 1. The role of glycogen synthase kinase-3beta in normal haematopoiesis, angiogenesis and leukaemia.
    Holmes T; O'Brien TA; Knight R; Lindeman R; Symonds G; Dolnikov A
    Curr Med Chem; 2008; 15(15):1493-9. PubMed ID: 18537625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation.
    Neumann M; Klar S; Wilisch-Neumann A; Hollenbach E; Kavuri S; Leverkus M; Kandolf R; Brunner-Weinzierl MC; Klingel K
    Oncogene; 2011 May; 30(21):2485-92. PubMed ID: 21217772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth.
    Holmes T; O'Brien TA; Knight R; Lindeman R; Shen S; Song E; Symonds G; Dolnikov A
    Stem Cells; 2008 May; 26(5):1288-97. PubMed ID: 18323411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
    Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
    J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
    Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
    Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of glycogen synthase kinase-3β (GSK-3β) inhibitor on Wnt and NF-κB signal pathways in a rat model of diabetic nephropathy].
    Zhou Y; Li L; Yu Y; Yang H; Yao H; Zhang Y; Zhang L; Deng C; Zhao L; Zhang Y; Song B
    Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):783-7. PubMed ID: 26888388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
    Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L
    Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells.
    Hu Y; Gu X; Li R; Luo Q; Xu Y
    J Exp Clin Cancer Res; 2010 Nov; 29(1):154. PubMed ID: 21110852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting glycogen synthase kinase-3β to prevent hyperoxia-induced lung injury in neonatal rats.
    Hummler SC; Rong M; Chen S; Hehre D; Alapati D; Wu S
    Am J Respir Cell Mol Biol; 2013 May; 48(5):578-88. PubMed ID: 23328640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design of benzo[e]isoindole-1,3-dione derivatives as selective GSK-3β inhibitors to activate Wnt/β-catenin pathway.
    Yue H; Lu F; Shen C; Quan JM
    Bioorg Chem; 2015 Aug; 61():21-7. PubMed ID: 26057861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
    Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
    Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
    Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
    Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
    Menon B; Johnson JN; Ross RS; Singh M; Singh K
    J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.
    Ougolkov AV; Fernandez-Zapico ME; Savoy DN; Urrutia RA; Billadeau DD
    Cancer Res; 2005 Mar; 65(6):2076-81. PubMed ID: 15781615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
    Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
    Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.
    Steinbrecher KA; Wilson W; Cogswell PC; Baldwin AS
    Mol Cell Biol; 2005 Oct; 25(19):8444-55. PubMed ID: 16166627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone.
    Ban JO; Kwak DH; Oh JH; Park EJ; Cho MC; Song HS; Song MJ; Han SB; Moon DC; Kang KW; Hong JT
    Chem Biol Interact; 2010 Oct; 188(1):75-85. PubMed ID: 20540935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles.
    Galliher-Beckley AJ; Williams JG; Collins JB; Cidlowski JA
    Mol Cell Biol; 2008 Dec; 28(24):7309-22. PubMed ID: 18838540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
    Kim SD; Yang SI; Kim HC; Shin CY; Ko KH
    Brain Res; 2007 Dec; 1186():12-20. PubMed ID: 17996850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.
    McCubrey JA; Steelman LS; Bertrand FE; Davis NM; Abrams SL; Montalto G; D'Assoro AB; Libra M; Nicoletti F; Maestro R; Basecke J; Cocco L; Cervello M; Martelli AM
    Leukemia; 2014 Jan; 28(1):15-33. PubMed ID: 23778311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.